Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Metabolic Triple GLP-1, GIP, and glucagon receptor agonist $99.99 10 mg vial 98% HPLC Purity Third-Party Tested COA per Batch Cold-Chain Ship About this compound Retatrutide is a synthetic 39-amino acid peptide and an investigational triple-receptor agonist targeting the GLP-1, GIP, and glucagon receptors simultaneously, making it one of the most pharmacologically novel research peptides in the metabolic research space
Mounjaro (tirzepatide) is a twincretin or GLP-1/GIP FDA-approved for type 2 diabetes, says Dr
Metabolic changes and ketones: Victoza works by enhancing insulin secretion in a glucose-dependent manner, slowing gastric emptying, and reducing appetite
The known microvascular diseases and disorders encompass a broad spectrum of conditions affecting small blood vessels (arterioles, capillaries, and venules) across multiple organ systems
